Stroke is a heterogeneous multifactorial disease and is thought to have a polygenic basis. Case–control studies on gene sequence variations have identified a number of potential genetic predisposition factors, but due to the conflicting results, uncertainty remains on the effect of these polymorphisms on risk for the development of stroke. To qualitatively and quantitatively assess the risk associated with different gene polymorphisms for stroke in Asian populations, we comprehensively searched and identified all the studies of association. Clinically overt case–control studies were selected only if neuroimaging had been used as the confirmatory measure for diagnosis of stroke. We performed a meta-analysis of the three most investigated genes, viz., methylenetetrahydrofolate reductase (MTHFR), apolipoprotein E (ApoE) and angiotensin-converting enzyme (ACE). Statistically significant association with stroke were identified for C677T polymorphism of MTHFR [random effects odds ratio (OR) = 1.47, 95% confidence interval (95% CI) 1.19, 1.82; P = 0.0004] and marginally significant association was detected with allele ɛ 4 of ApoE (random effects OR = 1.47, 95% CI 1.00, 2.15; P = 0.049). The sensitivity analysis (exclusion of studies with controls not in Hardy–Weinberg equilibrium) revealed a significant association of stroke with the MTHFR C677T and ApoE ɛ 4 alleles but showed no association with ACE gene insertion/deletion polymorphism.
Stroke is the third leading cause of death and the largest cause of disability among older people worldwide (Feigin et al. 2003). According to the World Health Organization estimates, annually, 15 million people worldwide suffer a stroke. Of these, 5 million die and another 5 million are left permanently disabled. In 2002, nearly 5.5 million people died of stroke, and more than 50% of these deaths occurred in Asian countries such as India, Pakistan, Bangladesh, China, Korea and Japan (WHO report: http://www.who.int/cardiovascular_diseases/). Although there has been a decline in the incidence of stroke in the Western population during the past three decades (Heart Disease and Stroke Statistics-2003 Update, American Heart Association), the burden of this disease has increased and is expected to rise in the South Asian countries (Bulatao et al. 1992). In various epidemiological studies in families (Jousilahti et al. 1997; Liao et al. 1997) and in twins (Brass et al. 1992; Bak et al. 2002), genetic factors were found to be involved in the predisposition of stroke in conjunction with the other risk factors.
A candidate gene case–control approach, examining polymorphisms, is generally taken to investigate genetic risk factors for stroke. Since stroke is a heterogeneous multifactorial disease, there is a large number of candidate genes, which are involved in blood coagulation, blood pressure regulation, cholesterol metabolism, etc. (Hassan and Markus 2000; Casas et al. 2004). However, uncertainty arises about the nature and number of genes involved in the development of stroke, due to lack of reproducibility of genetic case–control studies (Casas et al. 2004). In the association studies, there are possibilities that some positive results might be spurious and some negative findings might be a consequence of low statistical power (Casas et al. 2004). It could be due to their small sample size or methodological shortcomings, such as the selection of an appropriate control group (Hassan and Markus 2000; Casas et al. 2004; Dichgans and Markus 2005). Meta-analysis might be a means of resolving disparate results. For example, pooling samples from several studies could produce greater power than from individual studies or might amplify trends for association in small individual studies (Casas et al 2004). By increasing the statistical power, by taking into account all available published data, meta-analysis might be useful to identify the causative genes with reliability and to quantify with precision the genetic risks (Casas et al. 2004). We conducted a comprehensive meta-analysis of all genetic association studies in stroke in Asian populations and present our findings in this paper.
Materials and methods
Identification and selection of studies
A comprehensive literature search was conducted to collect data from all the studies that investigated association of genes with stroke in Asian populations. All the studies that were published before August 2006 were considered in the meta-analysis. We did extensive computer-based searches of PubMed to identify the case–control studies evaluating the role of any candidate gene in the development of stroke in Asian populations. The terms “stroke” and “polymorphism” were used as search criteria. The search results were limited to humans. Clinically overt case–control studies were selected only if neuroimaging [magnetic resonance imaging (MRI) or computed tomography (CT)] had been used as the confirmatory measure for diagnosis of stroke. Both ischaemic and haemorrhagic stroke types were considered for inclusion in the study, but other phenotypes, such as transient ischaemic attack (TIA), or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), were excluded. A majority of the articles covered in the present study were written in English. Articles in other languages were considered if the abstracts of the reports were given in English and if genotype frequencies and confirmation of diagnosis by neuroimaging were given. Those studies in which the genotype frequencies were not reported were excluded from our study.
We used a standard reporting form to extract data from each study that we included. We collected information on the name of the first author, year of publication, country, journal, racial descent of study population, demographics, number of cases and controls, genotype frequencies, allele frequencies (wherever available), and confirmation of diagnosis. Where allele frequencies were not given, they were calculated from the corresponding genotype frequencies of the case and the control groups.
Data synthesis and statistical analysis
Primary literature search generated 68 case–control studies of 30 candidate genes in which the presence or absence of stroke was determined in a dichotomous manner (Table 1). Methylenetetrahydrofolate reductase (MTHFR), apolipoprotein E (ApoE), and angiotensin-converting enzyme (ACE) were chosen for further analysis, as, on review, those three genes were found to be studied well in Asian populations. Ten studies of MTHFR (Morita et al. 1998; Zhang and Dai 2001; Wu et al. 2001; Li et al. 2002, 2003; Choi et al. 2003; Baum et al. 2004; Alluri et al. 2005; Fang et al. 2005; Gao et al. 2006), six studies for ApoE (Kokubo et al. 2000; Luthra et al. 2002; Um et al. 2003a; Jin et al. 2004; Lin et al. 2004; Gao et al. 2006), and six studies of ACE (Doi et al. 1997; Nakata et al. 1997; Um et al. 2001, 2003a; Li et al. 2002; Gao et al. 2006) gene polymorphisms were found to meet our selection criteria and were therefore included in the meta-analysis (Tables 2, 3 and 4). Because of unavailability of genotype data, two studies of ApoE polymorphism (Nakata et al. 1997; Chowdhury et al. 2001) were excluded for the present analyses. In one study, all the three polymorphisms were studied (Gao et al. 2006).
In the meta-analysis of MTHFR C677T polymorphism, the overall association of the T allele with risk of stroke was evaluated in comparison with the C allele. Also, the contrasts of homozygote TT versus CC, TT versus TC versus CC, TT versus (TC + CC), and (TT + TC) versus CC were examined.
In our study of ApoE polymorphisms, the risk of stroke associated with the ɛ 2 and ɛ 4 alleles relative to the ɛ 3 allele was examined. Furthermore, the contrasts of homozygotes ɛ 2 ɛ 2 and ɛ 4 ɛ 4 versus ɛ 3 ɛ 3, (ɛ 2 ɛ 2 + ɛ 2 ɛ 3 + ɛ 2 ɛ 4) versus ɛ 3 ɛ 3, and (ɛ 4 ɛ 4 + ɛ 2 ɛ 4 + ɛ 3 ɛ 4) versus ɛ 3 ɛ 3, were statistically evaluated.
The insertion/deletion polymorphism of the ACE gene was studied in the meta-analysis. The overall association of the D allele of the ACE gene relative to I allele and the contrasts of DD versus II, DD versus ID versus II, DD versus (ID + II), (DD + ID) versus II, were examined. For each gene variant, we evaluated the associations by calculating the odds ratios (ORs), together with the 95% confidence interval (CI), to measure the strength of the genetic association. Based on the individual ORs, a pooled odds ratio was calculated.
Using the Q-statistic, which is a weighted sum of squares of the deviations of individual study OR estimates from the overall estimate, heterogeneity between studies was examined (Cochran 1954). Q follows a chi-square distribution with r−1 (r is the number of studies) degrees of freedom (d.f.), when the ORs were homogeneous (Zintzaras et al. 2005). The heterogeneity was considered statistically significant if the P value was <0.10. Quantification of the heterogeneity was done with the I 2 metric (I 2 = (Q−d.f.)/Q), which is independent of the number of studies in the meta-analysis (Higgins and Thompson 2002). The I 2 values falls within the range 0–100%, with higher values denoting greater degree of heterogeneity (I 2 = 0–25%, no heterogeneity; I 2 = 25–50%, moderate heterogeneity; I 2 = 50–75%, large heterogeneity; I 2 = 75–100%, extreme heterogeneity) (Zintzaras et al. 2005). The Mantel–Haenszel method was used to calculate the fixed-effect pooled ORs (Mantel and Haenszel 1959; Robins et al. 1986). The random-effects pooled ORs were calculated by the DerSimonian and Liard method (DerSimonian and Laird 1986). Heterogeneity between studies is expected, because the studies that are brought together by systematic reviews are both clinically and methodologically diverse (Higgins et al. 2002). Where there was heterogeneity in studies, a pooled OR was estimated by the random-effects model, because this model assumes a genuine diversity in the results of the studies, incorporates the calculations of between-study variability, and provides wider CIs (Whitehead 2002; Zintzaras et al. 2005). To examine the trend of pooled OR for the allele contrasts in time, we carried out cumulative meta-analysis (Lau et al. 1992; Whitehead 1997) and recursive meta-analysis (Zintzaras et al. 2005). For assessment of publication bias for the allele contrast, the Egger regression test for funnel plot asymmetry (Egger et al. 1997; Ioannidis et al. 2003; Zintzaras et al. 2005) and the Begg–Mazumdar test, which is based on Kendall’s tau (Begg and Mazumdar 1994), were carried out. Sensitivity analyses were done to examine the effect of the studies with controls that are not in Hardy–Weinberg equilibrium by their exclusion (Zintzaras et al. 2005). Data were analysed with statistical analysis software StatsDirect, (version 2.5.7).
The studies of MTHFR gene polymorphisms that were included in our meta-analysis were composed of 3,074 stroke cases and 3,315 healthy controls in total. The prevalence of allele T was 44% and 38% for the case and the control groups, respectively. TT prevalence in the cases was 20%, while in controls it was 16%. The prevalence of CC among patients and controls was 33% and 41%, respectively. The proportion of the case and the control groups having CT genotype was 47% and 43%, respectively. The genotype and the allele frequencies of the individual studies are shown in Table 5. In the control group of one study (Li et al. 2003), the genotype distribution was not in Hardy–Weinberg equilibrium.
In all the studies of ApoE together, there were, in total, 1,353 stroke patients and 1,915 controls. The prevalence of allele ɛ 2 was 7% and 6% for the stroke cases and the control groups, while the prevalence of allele ɛ 4 for the same groups was 12% and 10%, respectively. In the cases and the controls, the prevalence of ɛ 2 ɛ 2 genotype was 2% and 1%, the prevalence of ɛ 4 ɛ 4 genotype was 2% and 1%, and the prevalence of ɛ 3 ɛ 3 genotype was 67% and 72%, respectively. The prevalence of ɛ 2 ɛ 3 genotype among the stroke patients and the healthy controls was both 9%, while for ɛ 2 ɛ 4 genotype it was 2% in both the groups. The ɛ 3 ɛ 4 genotype prevalence was 19% and 15% among the cases and the controls, respectively. The genotype and the allele frequencies of the individual studies are shown in Tables 6 and 7. Departure of the genotype frequencies from the Hardy–Weinberg equilibrium among controls was observed in four studies (Kokubo et al. 2000; Luthra et al. 2002; Um et al. 2003a; Lin et al. 2004).
In total, the studies of ACE gene polymorphism that were considered for our meta-analysis included 988 stroke patients and 1,441 control individuals. The prevalence of the D allele was 40% and 38% for the cases and the controls, respectively. The prevalence of DD genotype among patients and controls was 17% and 15%, respectively, while the prevalence of II genotype for both the groups was 38%. The prevalence of heterozygotes ID among the case and the control groups was 45% and 47%, respectively. The genotype and the allele frequencies of the individual studies are shown in Table 8. Assessment of Hardy–Weinberg equilibrium for the genotypes among the controls revealed significant deviation in two studies (Nakata et al. 1997; Li et al. 2002).
Our results show that the carriers of the MTHFR T allele were 1.47-times more likely to develop stroke, according to the random effects pooled OR [95% CI (1.19, 1.82)]; P = 0.0004. However, extreme inter-study OR heterogeneity (P < 0.0001, I 2 = 79%) was observed (Table 9; Fig. 1). With the exclusion of the study with controls not in Hardy–Weinberg equilibrium, i.e. in sensitivity analysis, the degree of heterogeneity between the studies did not decrease appreciably and remained extremely high (P = 0.0002, I 2 = 73%). The fixed and the random effects ORs in the sensitivity analysis were significant: OR = 1.53 [95% CI (1.36, 1.72)]; P < 0.0001 and OR = 1.55 [95% CI (1.21, 1.99)]; P = 0.0006, respectively. The genotype contrast of the homozygotes as well as the additive, dominant and recessive models showed significant association, even in the sensitivity analyses. The random effects pooled OR of the allelic contrast was found to decline from 1.78 in 1998 (first study) to 1.39 in 2003 (six studies) and then increased to 1.47 in 2006, according to the cumulative and the recursive meta-analyses. Although the Begg–Mazumdar test, being of low power due to small numbers of studies, indicated low probability of publication bias (P > 0.99), the Egger test result was found to be significant (P = 0.04), suggesting the presence of publication bias.
In the meta-analysis of ApoE gene polymorphism (Table 10; Figs. 2 and 3), the association of allele ɛ 2 and the risk of developing stroke, in comparison with the ɛ 3 allele, showed non-significant result, the random effects pooled OR = 0.97 [95% CI (0.62, 1.53)]; P = 0.912, while, for the allele ɛ 4, the random effects pooled OR was marginally significant: OR = 1.47 [95% CI (1.00, 2.15)]; P = 0.049. High level of inter-study heterogeneity was found to exist in both cases (P = 0.0007, I 2 = 77%) and (P = 0.0015, I 2 = 74%), respectively. Taking into account only those studies with controls in Hardy–Weinberg equilibrium, we found that the ɛ 4 versus ɛ 3 allele contrast showed significant association, random effects OR = 2.09 [95% CI (1.37, 3.20)]; P = 0.0006. The genotype contrast ɛ 2 ɛ 2 versus ɛ 3 ɛ 3, under the fixed effects model, showed high significance, OR = 1.94 [95% CI (1.07, 3.51)]; P = 0.018, but was found to be non-significant in the random effects model, OR = 0.92 [95% CI (0.17, 4.78)]; P = 0.92. Large heterogeneity (P = 0.003, I 2 = 75%) between the studies was found to exist. Although the odds ratios in the genotype contrast ɛ 4 ɛ 4 versus ɛ 3 ɛ 3 indicated increased risk for stroke in both the fixed effects and the random effects models, the results were not statistically significant, the fixed effects OR = 1.43 [95% CI (0.79, 2.61)]; P = 0.304, and the random effects OR = 1.41 [95% CI (0.76, 2.63)]; P = 0.274. In that genotype contrast, no inter-study heterogeneity was found to exist (P = 0.545, I 2 = 0%). The genotype contrast (ɛ 4 ɛ 4 + ɛ 2 ɛ 4 + ɛ 3 ɛ 4) versus ɛ 3 ɛ 3 in the fixed effects model showed significant association, OR = 1.32 [95% CI (1.09, 1.60)]; P = 0.004, but the association according to the random effects model was marginally significant, OR = 1.56 [95% CI (0.99, 2.44)]; P = 0.05, although extreme heterogeneity (P = 0.0007, I 2 = 76%) was found to exist between the studies. Cumulative and recursive meta-analysis for the allele contrast ɛ 2 versus ɛ 3 showed that the random effects pooled OR decreased from 2.15 in 2000 (first study) to 1.08 in 2004 (five studies), and then further decreased to 0.97 in 2006 (six studies), while an ascending trend was observed for the allele contrast ɛ 4 versus ɛ 3, where the random effects OR increased from 1.19 in 2000 (first study) to 1.47 in 2004 (five studies) but then remained unchanged till 2006 (six studies). The Egger test and the Begg–Mazumdar test results suggested a low probability of publication bias for the allele contrast ɛ 2 versus ɛ 3 (P = 0.151 and P = 0.469, respectively) and the allele contrast ɛ 4 versus ɛ 3 (P = 0.168 and P = 0.272, respectively).
In the meta-analysis of ACE insertion/deletion (I/D) polymorphism (Table 11; Fig. 4), the summary ORs under a fixed effects and a random effects model showed no statistically significant association of the D allele with the risk of developing stroke relative to the I allele, OR = 1.06 [95% CI (0.94, 1.20)]; P = 0.3, for either model. No heterogeneity was observed between the six studies (P = 0.842, I 2 = 0%). In the sensitivity analysis (exclusion of the studies in which there was no deviation from Hardy–Weinberg equilibrium among the controls), the fixed effects model and the random effects model both showed non-significant association, OR = 1.07 [95% CI (0.93, 1.24)]; P = 0.3, for either model. No inter-study heterogeneity (P = 0.619, I 2 = 0%) was found to exist in this analysis. No significant association was found either in the genotype contrast for homozygous alleles or with the additive or the dominant or the recessive models. In the cumulative and the recursive meta-analysis for the allelic contrast it was found that there was a slight decline in the random effects pooled OR, from 1.19 in 1997 (first study) to 1.06 in 2002 (four studies). After that, there was no further change in the random effects pooled OR till 2006 (six studies). Both the Egger test and the Begg–Mazumdar test results suggested a low probability of publication bias (P = 0.134 and P = 0.136, respectively).
In this comprehensive meta-analysis, two of the three candidate gene polymorphisms showed significant association with stroke in the Asian populations. The relationships between the gene variants analysed in our meta-analysis and stroke have been implicated in a large number of subjects in the association studies, but the individual studies were generally small and had several methodological limitations. Because of the contradictory results of the association studies of the gene variants and stroke in the Asian populations, a prospective study was necessary to evaluate the candidacy of those genes, with reliability, in the pathogenesis of stroke. Our study, in the context of the Asian populations, presented an overview of the studies of the gene variants that have been examined for their association with stroke and evaluated and quantified the risks associated with the most studied polymorphisms for the development of stroke.
Of the three genes that have been studied extensively in Asian populations, MTHFR C677T polymorphism studies included the maximum number of cases (total number of stroke cases = 3,074). The MTHFR encoded product 5,10-methylenetetrahydrofolate reductase is a folate-dependent enzyme catalysing the rate-limiting step in the methylation of homocysteine to methionine. The C677T polymorphism in MTHFR results in the conversion of alanine to valine at amino acid 222 and was reported to be associated with decreased activity and, eventually, elevation of homocysteine levels (Kang et al. 1991; Frosst et al. 1995). Elevated level of homocysteine causes endothelial dysfunction (Constans et al. 1999) and was found to be a risk factor for atherosclerosis and atherothrombosis (McCully 1969; Frosst et al. 1995). The C677T transition was reported to be associated with ischaemic stroke (Morita et al. 1998). Data from ten case–control studies of the MTHFR polymorphism and stroke were included for this meta-analysis. The studies were composed of a total of 3,074 stroke patients and 3,315 healthy controls. The overall results indicated a significant association of the C677T MTHFR polymorphism with stroke, but with large inter-study heterogeneity. Although a high level of heterogeneity persisted, even in the sensitivity analysis, the results showed significant association. Our findings of the association of MTHFR C677T polymorphism in this meta-analysis are in agreement with the previously conducted meta-analyses where this polymorphism was found to be potentially involved in the development of stroke (Cronin et al. 2005; Casas et al. 2004; Kim and Becker 2003; Kelly et al. 2002).
The protein product of the apolipoprotein E (ApoE) gene is a glycoprotein with three common isoforms: E2, E3, and E4, encoded by the alleles ɛ 2, ɛ 3, and ɛ 4, respectively. The genotype ɛ 3 ɛ 3 occurs in approximately one-half to two-thirds in most populations (Sudlow et al. 2006). The major role of this protein is lipid transport and metabolism. It was found that the genotypes having the ɛ 4 allele are associated with increased cholesterol levels, in comparison with the ɛ 3 ɛ 3 genotype, while genotypes with the ɛ 2 allele were found to be associated with decreased levels (Eichner et al. 2002). The potential role of ApoE in the repair and regeneration of neurons and survival after brain injury was found in rodent models of head injury and ischaemic stroke (Graham et al. 1999; Horsburgh et al. 2000). Clinical studies have shown that genotypes with the ɛ 4 allele are associated with poor outcome after head injury (Waters and Nicoll 2005). According to these observations, it can be suggested that ApoE might influence outcome after acute stroke in humans (Waters and Nicoll 2005). Since different studies have produced conflicting results, there was the necessity of the conducting of a comprehensive meta-analysis. In our study, the allele ɛ 4 was found to be associated with stroke, but high heterogeneity existed between the studies.
The function of the angiotensin-converting enzyme (ACE) is the conversion of angiotensin I to angiotensin II, which is involved in vasoconstriction, vascular hypertrophy, and atherosclerosis (Kim and Iwao 2000). ACE also inhibits the functions of bradykinin, a vasoactive peptide that is involved in vasodilatation, by its degradation (Kim and Iwao 2000). The ACE I/D polymorphism partly determines the plasma and intracellular levels of ACE in stroke patients and healthy individuals (Tiret et al. 1992; Sharma et al. 1994). Patients with a double deletion of a 287 bp in intron 16 (DD genotype) have higher plasma or tissue levels of ACE than do individuals with ID or II genotype (Rigat et al. 1990; Tiret et al 1992). To explore whether I/D polymorphism within intron 16 of the ACE gene confers susceptibility to stroke, we conducted a meta-analysis taking six studies. No statistically significant association with stroke was detected, either for the D allele or for the homozygous DD genotype. However, no heterogeneity was found to exist between the studies. Results did not change, either for the allele or for the genotypes, in the sensitivity analysis. Since the sample size was relatively small for ACE I/D polymorphism studies, these results should be considered with caution.
Although we tried to estimate a combined effect from groups of similar studies only in the Asian population, we found considerable heterogeneity among the studies of the MTHFR and ApoE polymorphisms. In the sensitivity analysis of ApoE polymorphism, the measures of heterogeneity dropped to null in most of the genotype and the allele contrasts. Although only two studies were considered for this analysis, the results indicate that the departure of the genotype frequencies from Hardy–Weinberg equilibrium in the control populations could be a possible cause for the inter-study heterogeneity. The sensitivity analysis of the MTHFR polymorphism, however, failed to change the effect of heterogeneity in an appreciable manner, except for the additive and the dominant models. Thus, in addition to the departure of the genotype frequencies from the Hardy–Weinberg equilibrium in the control populations, the cause of this observed heterogeneity could be attributable to the variations in genetic constitution and/or environmental characteristics across the populations or to the difference in the design and conduct of the studies. As evident from the observed results, homogeneity existed among the studies on ACE I/D polymorphism. It is interesting to note that many of the studies that were analysed had control groups whose genotype frequencies deviated significantly from the Hardy–Weinberg equilibrium (Li et al. 2003, 2002; Kokubo et al. 2000; Luthra et al. 2002; Um et al. 2003a; Lin et al. 2004; Nakata et al. 1997). Potential biases in the selection of control individuals, or genotyping errors, could be implicated in such deviations (Little et al. 2002).
Since we considered only the Asian population for our analyses, we looked for reports of other meta-analyses conducted with data from the European population to compare whether ethnic variations between these two populations have any effect on the association of the gene polymorphisms that we studied with the risk of developing stroke. The MTHFR C677T polymorphism was reported to be significantly associated with increased risk of stroke in the European population (Casas et al. 2004) and in the Asian as well as the European populations (Cronin et al. 2005). No evidence of association was found to exist between the ApoE polymorphism and stroke in the European population (Casas et al. 2004), and a stronger association with stroke was found in the Asian populations than in white populations (Sudlow et al. 2006). Association of the ACE I/D polymorphism with increased risk of stroke in the European populations was evidenced from two meta-analyses (Casas et al. 2004; Sharma 1998).These reports, in conjunction with our results, suggest that ethnic variations among these two populations could be accounted for by the discordant findings on the roles ApoE and the ACE polymorphisms in the pathogenesis of stroke. Interestingly, no such discordance was observed in the case of the MTHFR polymorphism, and, in both the populations, this C677T polymorphism was found to be a potent risk factor for the development of stroke.
In conclusion, the evidence from these meta-analyses supports the notion of a role for the polymorphisms of MTHFR and ApoE genes in susceptibility to stroke. Meta-analysis of the ACE gene polymorphism has failed to provide evidence of increased risk for stroke. In our analyses we tested various allele and genotype contrasts for each of the three genes. However, such comparisons are not independent of each other and, therefore, might pose multiple-comparison problems. To confirm or refute these findings, additional larger studies with corrections for multiple comparisons are required.
Alluri RV, Mohan V, Komandur S, Chawda K, Chaudhuri JR, Hasan Q (2005) MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study. Eur J Neurol 12:40–44
Bak S, Gaist D, Sindrup SH, Skytthe A, Christensen K (2002) Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 33:769–774
Baum L, Wong KS, Ng HK, Tomlinson B, Rainer TH, Chan DK, Thomas GN, Chen X, Poon P, Cheung WS, Woo KS (2004) Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke. Clin Chem Lab Med 42:1370–1376
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD (1992) A study of twins and stroke. Stroke 23:221–223
Bulatao RA, Stephens PW (1992) Global estimates and projections of mortality by cause. Population, Health and Nutrition Department, Washington, DC, World Bank, preworking paper; p 1007
Casas JP, Hingorani AD, Bautista LE, Sharma P (2004) Meta-analysis of genetics studies in ischemic stroke. Thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 61:1652–1662
Chen CH, Eng HL, Chang CJ, Tsai TT, Lai ML, Chen HY, Liu CJ, Lin TM (2003) 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. J Lab Clin Med 142:100–105
Chen CH, Lo YK, Ke D, Liu CK, Liou CW, Wu HL, Lai ML, Southern Taiwan Young Stroke Study Group (2004) Platelet glycoprotein Ia C807T, Ib C3550T, and IIIa Pl(A1/A2) polymorphisms and ischemic stroke in young Taiwanese. J Neurol Sci 227:1–5
Choi BO, Kim NK, Kim SH, Kang MS, Lee S, Ahn JY, Kim OJ, Kim S, Oh D (2003) Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb Res 111:39–44
Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H (2001) Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol 11:131–138
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
Constans J, Blann AD, Resplandy F, Parrot F, Seigneur M, Renard M, Amiral J, Guerin V, Boisseau MR, Conri C (1999) Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients. Atherosclerosis 147:411–413
Cronin S, Furie KL, Kelly PJ (2005) Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 36:1581–1587
Dai K, Gao W, Ruan C (2001) The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke. Thromb Res 104:389–395
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Dichgans M, Markus HS (2005) Genetic association studies in stroke. Methodological issues and proposed standard criteria. Stroke 36:2027–2031
Doi Y, Yoshinari M, Yoshizumi H, Ibayashi S, Wakisaka M, Fujishima M (1997) Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction. Atherosclerosis 132:145–150
Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487–495
Fang L, Wu W, Wu YQ (2004) Relationship between polymorphisms of cystathionine beta-synthase gene and stroke. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 16:161–164
Fang X, Namba H, Akamine S, Sugiyama K (2005) Methylenetetrahydrofolate reductase gene polymorphisms in patients with cerebral hemorrhage. Neurol Res 27:73–76
Feigin VL, Lawes CM, Bennett DA, Anderson CS (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43–53
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113
Gao XG, Huo Y, Liu XZ, Teng ZP (2005) Gene polymorphism of platelet glycoprotein I b alpha in Chinese patients with large- and small-artery subtypes of ischemic stroke. Eur Neurol 54:73–77
Gao X, Yang H, ZhiPing T (2006) Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neurosci Lett 398:172–177
Graham DI, Horsburgh K, Nicoll JA, Teasdale GM (1999) Apolipoprotein E and the response of the brain to injury. Acta Neurochir Suppl 73:89–92
Hassan A, Markus HS (2000) Genetics and ischemic stroke. Brain 123:1784–1812
Higgins JP, Thompson SE (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Higgins J, Thompson S, Deeks J, Altman D (2002) Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 7:51–61
Hiramoto M, Yoshida H, Imaizumi T, Yoshimizu N, Satoh K (1997) A mutation in plasma platelet-activating factor acetylhydrolase (Val279−>Phe) is a genetic risk factor for stroke. Stroke 28:2417–2420
Horsburgh K, McCarron MO, White F, Nicoll JA (2000) The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models. Neurobiol Aging 21:245–255
Hou L, Osei-Hyiaman D, Yu H, Ren Z, Zhang Z, Wang B, Harada S (2001) Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurology 56:490–496
Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y (2000) Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149:435–442
Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG (2003) Genetic associations in large versus small studies: an empirical assessment. Lancet 361:567–571
Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, Fukuuchi Y (2000a) C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31:936–939
Ito D, Murata M, Tanahashi N, Sato H, Sonoda A, Saito I, Watanabe K, Fukuuchi Y (2000b) Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 31:2661–2664
Ito D, Tanahashi N, Murata M, Sato H, Saito I, Watanabe K, Fukuuchi Y (2002) Notch3 gene polymorphism and ischaemic cerebrovascular disease. J Neurol Neurosurg Psychiatry 72:382–384
Jin ZQ, Fan YS, Ding J, Chen M, Fan W, Zhang GJ, Zhang BH, Yu SJ, Zhang YS, Ji WF, Zhang JG (2004) Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population. Acta Pharmacol Sin 25:352–356
Jousilahti P, Rastenyte D, Tuomilehto J, Sarti C, Vartiainen E (1997) Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14 371 middle-aged men and women in Finland. Stroke 28:1361–1366
Kang SS, Wong PW, Bock HG, Horwitz A, Grix A (1991) Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. Am J Hum Genet 48:546–551
Kang WY, Wang HL, Xiong LF, Wang XF, Chu HY, Qu B, Liu XF, Yin J, Duan BH, Wang ZY (2004) Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations. Chin Med J (Engl) 117:71–74
Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, Furie KL (2002) Homocysteine, MTHFR 677C−>T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59:529–536
Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146:948–957
Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52:11–34
Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H (2000) Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 31:1299–1306
Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248–254
Lee BC, Ahn SY, Doo HK, Yim SV, Lee HJ, Jin SY, Hong SJ, Lee SH, Kim SD, Seo JC, Leem KH, Chung JH (2004) Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett 357:33–36
Li C, Zhang C, Qiu S, Lu X, Zeng Y, Wu H, Chen W, Luo W, Liu J (2002) Polymorphisms of ACE-1 and MTHFR genes and genetic susceptibility of ischemic stroke. Zhonghua Yi Xue Za Zhi 82:1046–1049
Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Ma A, Han Y, Wang Y, Shi Y, Ye J, Hui R (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a multicenter case–control study in China. Stroke 34:2085–2090
Liao D, Myers R, Hunt S, Shahar E, Paton C, Burke G, Province M, Heiss G (1997) Family history of stroke and stroke risk. The Family Heart Study. Stroke 28:1908–1912
Lin HF, Lai CL, Tai CT, Lin RT, Liu CK (2004) Apolipoprotein E polymorphism in ischemic cerebrovascular diseases and vascular dementia patients in Taiwan. Neuroepidemiology 23:129–134
Lin YC, Chang YM, Yu JM, Yen JH, Chang JG, Hu CJ (2005) Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 180:305–309
Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O’Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S, Weinberg C (2002) Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 156:300–310
Liu Y, Pan J, Wang S, Li X, Huang Y (2002) Beta-fibrinogen gene −455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients. Chin Med J (Engl) 115:214–216
Luthra K, Prasad K, Kumar P, Dwivedi M, Pandey RM, Das N (2002) Apolipoprotein E gene polymorphism in cerebrovascular disease: a case–control study. Clin Genet 62:39–44
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111–128
Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Kitamura K, Yazaki Y (1998) Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 18:1465–1469
Morita H, Kurihara H, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y (1999) Polymorphism of the methionine synthase gene: association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol 19:298–302
Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, Ohishi M, Miki T, Higaki J, Ogihara T (1997) Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 10:1391–1395
Nakayama T, Asai S, Sato N, Soma M (2006) Genotype and haplotype association study of the STRK1 region on 5q12 among Japanese: a case–control study. Stroke 37:69–76
Nishiuma S, Kario K, Yakushijin K, Maeda M, Murai R, Matsuo T, Ikeda U, Shimada K, Matsuo M (1998) Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population. Blood Coagul Fibrinolysis 9:373–379
Park MH, Min JY, Koh SB, Kim BJ, Park MK, Park KW, Lee DH (2006) Helicobacter pylori infection and the CD14 C(−260)T gene polymorphism in ischemic stroke. Thromb Res 118:671–677
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346
Robins J, Greenland S, Breslow NE (1986) A general estimator for the variance of the Mantel–Haenszel odds ratio. Am J Epidemiol 124:719–723
Saleheen D, Bukhari S, Haider SR, Nazir A, Khanum S, Shafqat S, Anis MK, Frossard P (2005) Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population. Stroke 36:2275–2277
Seo JC, Han SW, Yin CS, Koh HK, Kim CH, Kim EH, Leem KH, Lee HS, Park HJ, Kim SA, Choe BK, Lee HJ, Yim SV, Kim CJ, Chung JH (2002) Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patients. Exp Mol Med 34:294–298
Sharma P (1998) Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 64:227–230
Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM (1994) Polymorphisms in the gene encoding angiotensin 1-converting enzyme and relationship to its post-translational product in cerebral infarction. J Hum Hypertens 8:633–634
Shimo-Nakanishi Y, Urabe T, Hattori N, Watanabe Y, Nagao T, Yokochi M, Hamamoto M, Mizuno Y (2001) Polymorphism of the lipoprotein lipase gene and risk of atherothrombotic cerebral infarction in the Japanese. Stroke 32:1481–1486
Shimo-Nakanishi Y, Hasebe T, Suzuki A, Mochizuki H, Nomiyama T, Tanaka Y, Nagaoka I, Mizuno Y, Urabe T (2004) Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175:109–115
Sonoda A, Murata M, Ito D, Tanahashi N, Ohta A, Tada Y, Takeshita E, Yoshida T, Saito I, Yamamoto M, Ikeda Y, Fukuuchi Y, Watanabe K (2000) Association between platelet glycoprotein Ibalpha genotype and ischemic cerebrovascular disease. Stroke 31:493–497
Sudlow C, Martinez Gonzalez NA, Kim J, Clark C (2006) Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke 37:364–370
Sun L, Li Z, Zhang H, Ma A, Liao Y, Wang D, Zhao B, Zhu Z, Zhao J, Zhang Z, Wang W, Hui R (2003) Pentanucleotide TTTTA repeat polymorphism of apolipoprotein(a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case–control study in China. Stroke 34:1617–1622
Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197–205
Ueno T, Shimazaki E, Matsumoto T, Watanabe H, Tsunemi A, Takahashi Y, Mori M, Hamano R, Fujioka T, Soma M, Matsumoto K, Kanmatsuse K (2003) Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese populations. Med Sci Monit 9:CR208–CR212
Um JY, Kim HM (2004) Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res Mol Brain Res 122:99–102
Um JY, Kim HJ, Choi TJ, Jin CS, Park ST, Lee KC, Rhee HS, Lee KM, Lee YM, Kim HM, An NH, Kim JJ (2001) Polymorphism of the angiotensin-converting enzyme gene in patients with cerebral infarction in Koreans. J Mol Neurosci 17:279–283
Um JY, Moon KS, Lee KM, Cho KH, Heo Y, Moon BS, Kim HM (2003a) Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction. J Mol Neurosci 21:23–28
Um JY, Moon KS, Lee KM, Kim HM (2003b) Interleukin-1 gene cluster polymorphisms in cerebral infarction. Cytokine 23:41–46
Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS, Kim HM (2003c) Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res Mol Brain Res 115:50–54
Um JY, An NH, Kim HM (2003d) TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 21:167–171
Waters RJ, Nicoll JA (2005) Genetic influences on outcome following acute neurological insults. Curr Opin Crit Care 11:105–110
Whitehead A (1997) A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials. Stat Med 16:2901–2913
Whitehead A (2002) Meta-analysis of controlled clinical trials. Wiley, Chichester
Wu Y, Tomon M, Sumino K (2001) Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke: sex difference in Japanese. Kobe J Med Sci 47:255–262
Xia J, Yang Q, Yang Q, Xu H, Zhang L (2003) The relationship of apolipoprotein H G1025C (Try316Ser) polymorphism with stroke and its effect on plasma lipid levels in Changsha Hans. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20:114–118
Xia J, Yang QD, Yang QM, Xu HW, Liu YH, Zhang L, Zhou YH, Wu ZG, Cao GF (2004) Apolipoprotein H gene polymorphisms and risk of primary cerebral hemorrhage in a Chinese population. Cerebrovasc Dis 17:197–203
Zhan M, Zhou Y, Han Z (2003) Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. Chin Med J (Engl) 116:1707–1710
Zhang G, Dai C (2001) Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res 104:187–195
Zhang Y, Xie R, Wang Y, Chen D, Wang G, Xu X (2002) Association of estrogen receptor gene polymorphism with cerebral infarction, a case–control study. Zhonghua Yi Xue Za Zhi 82:1443–1446
Zhang L, Zhang H, Sun K, Song Y, Hui R, Huang X (2005) The 825C/T polymorphism of G-protein beta3 subunit gene and risk of ischaemic stroke. J Hum Hypertens 19:709–714
Zhao SP, Tong QG, Xiao ZJ, Cheng YC, Zhou HN, Nie S (2003) The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese. Clin Chim Acta 330:161–164
Zintzaras E, Chatzoulis DZ, Karabatsas CH, Stefanidis I (2005) The relationship between C677T methylenetetrahydrofolate reductase gene polymorphism and retinopathy in type 2 diabetes: a meta-analysis. J Hum Genet 50:267–275
This work was supported by a research grant from the Indian Institute of Technology, Kanpur (IITK), to S.G. I.B. and V.G. received studentships from the IITK.
About this article
Cite this article
Banerjee, I., Gupta, V. & Ganesh, S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 52, 205–219 (2007). https://doi.org/10.1007/s10038-006-0098-x
This article is cited by
A prospective cohort study of MTHFR C677T gene polymorphism and its influence on the therapeutic effect of homocysteine in stroke patients with hyperhomocysteinemia
BMC Neurology (2020)
Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India
Metabolic Brain Disease (2018)
Insertion/Insertion Genotype of Angiotensin I-Converting-Enzyme Gene Predicts Risk of Myocardial Infarction in North East India
Biochemical Genetics (2016)
The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review
Molecular Biology Reports (2014)
Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cell anaemia
Annals of Hematology (2014)